Skip to main content
Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · IEX Real-Time Price · USD
13.36
-0.13 (-0.96%)
At close: Jul 19, 2024, 4:00 PM
13.30
-0.06 (-0.45%)
After-hours: Jul 20, 2024, 12:57 PM EDT

Takeda Pharmaceutical Revenue

In the fiscal year ending March 31, 2024, Takeda Pharmaceutical had annual revenue of $28.16B. Revenue in the quarter ending March 31, 2024 was $6.94B.

Revenue (ttm)
$28.16B
Revenue Growth
-7.42%
P/S Ratio
1.50
Revenue / Employee
$571,462
Employees
49,281
Market Cap
42.15B USD

Revenue Chart

* The company reports in JPY currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 202428.16B-2.26B-7.42%
Mar 31, 202330.42B1.14B3.90%
Mar 31, 202229.28B-86.52M-0.29%
Mar 31, 202129.36B-1.14B-3.73%
Mar 31, 202030.50B11.44B59.98%
Mar 31, 201919.07B3.58B23.08%
Mar 31, 201815.49B-142.02M-0.91%
Mar 31, 201715.63B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cencora 276.54B
Humana 109.24B
GE HealthCare Technologies 19.50B
IQVIA Holdings 15.07B
Haleon 14.31B
Alcon 9.56B
Agilent Technologies 6.59B
Moderna 5.15B
Revenue Rankings

TAK News

More News